Clinical Trial Update: Ph3 Study of Exemestane With or Without Entinostat in Chinese Patients With Hormone Receptor-Positive, Locally Advanced or Metastatic Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating exemestane with or without entinostat in Chinese patients with hormone receptor-positive, locally advanced or metastatic breast cancer;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Entinostat (entinostat)
• Exemestane (Exemestane)

Snippet

Sponsor: Taizhou EOC Pharma Co., Ltd. | Conditions: Advanced Breast Cancer | Phase 3 | Status: UNKNOWN